SIX Swiss Exchange · Technology
Invest in Ascom stock from India
Indian and foreign residents can buy Ascom (ASCN) shares directly through Paasa.
By Paasa · Updated
Ascom at a glance
- Price
- CHF 5.80+CHF 0.09 (1.58%)
- Market cap
- CHF 198.14M
- Day range
- CHF 5.71 – CHF 5.81
- P/E
- 11.15
- Dividend yield
- 3.45%
- Volume
- 41.49K
- 1 month
- +6.42%
- 6 months
- +16.00%
- YTD
- +51.83%
- 1 year
- +64.77%
- 5 years
- -60.76%
Ascom statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 292.1M | CHF 286.7M | CHF 297.3M | CHF 297.4M | CHF 291.5M |
| Gross profit | CHF 140.7M | CHF 133.3M | CHF 141.4M | CHF 135.4M | CHF 135.6M |
| Operating income | CHF 20.2M | CHF 7.6M | CHF 20.2M | CHF 14.0M | CHF 15.8M |
| Net income | CHF 15.1M | CHF 3.7M | CHF 17.4M | CHF 11.0M | CHF 13.5M |
| Earnings per share | CHF 0.43 | CHF 0.10 | CHF 0.48 | CHF 0.31 | CHF 0.38 |
| EBITDA | CHF 34.2M | CHF 13.8M | CHF 31.3M | CHF 25.9M | CHF 28.8M |
| Total assets | CHF 199.6M | CHF 189.9M | CHF 197.2M | CHF 201.8M | CHF 194.7M |
| Total debt | CHF 0.0 | CHF 0.0 | CHF 0.0 | CHF 10.0M | CHF 0.0 |
| Cash and short-term investments | CHF 29.6M | CHF 18.6M | CHF 24.7M | CHF 26.6M | CHF 29.5M |
| Shareholders' equity | CHF 79.9M | CHF 74.4M | CHF 78.7M | CHF 73.4M | CHF 80.0M |
| Operating cash flow | CHF 32.6M | CHF 20.0M | CHF 32.5M | CHF 10.2M | CHF 11.6M |
| Free cash flow | CHF 31.6M | CHF 15.6M | CHF 16.3M | −CHF 3.2M | −CHF 100.0K |
| Capital expenditure | −CHF 1.0M | −CHF 4.4M | −CHF 16.2M | −CHF 13.4M | −CHF 11.7M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| DocMorris | DOCM.SW | CHF 12.39 | CHF 605.73M |
| IVF Hartmann | VBSN.SW | CHF 129.50 | CHF 308.39M |
| COLTENE | CLTN.SW | CHF 47.00 | CHF 280.84M |
| Santhera Pharmaceuticals | SANN.SW | CHF 15.08 | CHF 223.66M |
| Newron Pharmaceuticals | NWRN.SW | CHF 8.14 | CHF 169.36M |
| Molecular Partners | MOLN.SW | CHF 3.31 | CHF 124.16M |
| SHL Telemedicine | SHLTN.SW | CHF 1.07 | CHF 39.65M |
| Relief Therapeutics | RLF.SW | CHF 2.89 | CHF 36.28M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Ascom from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search ASCN and buy
Find Ascom by name or by its ticker, ASCN, and place your order.
Why invest in Ascom from India
What Ascom does
Ascom Holding AG, operating globally through its subsidiaries, specializes in providing information and communication technology (ICT) and mobile workflow solutions, primarily for the healthcare industry. Their comprehensive product portfolio features advanced nurse call and patient monitoring systems. Ascom operates in the Communication Equipment industry within the Technology sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Ascom stock from India?
Yes. Indian residents and NRIs can buy Ascom (ASCN) shares directly through Paasa. Ascom is listed on the SIX Swiss Exchange, in the Communication Equipment industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Ascom shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.